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The burden of cancer in low and middle income countries (LMICs) continues to rise (1). Evaluation of 
geographical differences in cancer mortality statistics is specifically of interest in LMICs as 
(inter)national guidelines are potentially less embedded in standard care and objective 
measurements to assess underlying mechanisms/explanations for the burden of cancer are often 
lacking. Monitoring mortality statistics in these countries can thus help assess the effectiveness of 
national and regional health systems in treating and caring for patients with cancer (1). 
 
Torres-Roman et al. deserve to be congratulated for their efforts to monitor mortality rates for 
prostate cancer at both a regional and national level in Peru (2). The CONCORD initiative from the 
World Health Organisation (WHO) previously reported prostate cancer statistics for Peru, but data 
were limited to the capital area of Lima (1). Torres-Raman et al. report prostate cancer mortality 
rates between2005-2014 based on data from the Peruvian Ministry of Health, which covers about 
70% of all health care providers in Peru. Apart from an overall increase of 15% in mortality rates, 
substantial variation was observed by geographical region. Mortality rates increased by 16% in the 
coastal region and highlands, whereas in the rainforest region the rates decreased by 19% (2). One 
potential explanation for these observed differences could be the difference in ethnic and racial 
characteristics. The coastal region in Peru has a strong African influence and also has a larger 
proportion of men above the age of 65 years. In addition to potential differences in access to 
healthcare, some of the variation in prostate cancer mortality statistics most likely reflects deficiency 
in reporting systems. Even though this study has its limitations due to missingness and lack of 
information on other important variables such as ethnicity and socioeconomic status, it provides a 
first bases for a critical assessment of prostate cancer care in Peru.  
 
Studies like the one from Torres-Roman et al. show that there is a need for improvement and 
standardisation of (prostate) cancer care in LMICs, but also a need for improvement in data 
capturing so that objective measurements can be put in place. The years of healthy life lost due to 
prostate cancer as well as other urological cancers in LMICs is increasing substantially. Even though 
each tumour group has its own specifications in terms of prevention and control, an epidemiological 
assessment of cancer burden based on the experience for urological cancers (i.e. prostate, bladder, 
kidney, and testicular) can therefore inform future assessments of cancer burden. The urological 
tumour group covers both common and less common cancers (e.g. prostate vs. kidney cancer), sex-
specific and cancers that affect both sexes (e.g. testicular vs. bladder cancer), cancers with less 
known risk factors and those strongly linked with lifestyle risk factors (e.g. prostate vs. bladder 
cancer). 
 
It is encouraging to see an increase in the number of studies evaluating the burden of cancer in 
LMICs (3), however given the consistency in observations of an increase in mortality, there is an 
urgent need to further invest in prevention and management as well as the infrastructure to collect 
all relevant data at a national level in these LMICs. Accurate information about - cancer burden and 
how this varies between regions is essential to plan for an adequate health-system response. 
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